Overview - Bayer Investor Relations

Create Value for our

Shareholders

We want to create value for our shareholders through innovation, growth and high earning power.

Investor News

June 19, 2019

Not intended for U.S. and UK Media

Regorafenib to be tested in brain cancer patients in multi-arm cooperation trial

June 03, 2019

Not intended for U.S. and UK Media - Annual Meeting of the American Society of Clinical Oncology (ASCO) 2019:

New data on larotrectinib efficacy in patients with TRK fusion cancer and primary CNS tumors or brain metastases presented at ASCO 2019

News Overview

August 1 - 2, 2019

St. Louis, Missouri, U.S.A.

Crop Science Summer Technology Showcase 2019

April 25, 2019

Investor Conference Call

Publication of Q1 2019 Results

QUARTERLY STATEMENT

Quarterly Statement Q1 2019

On April 25, 2019, our Quarterly Statement Q1 2019 will be published.

ALL IN ONE

Get all Q1 2019 materials in one package

Download all documents on our First Quarter 2019 results in one ZIP file.

Download

Services

Tailored to your interest

Key Messages

Read Key Messages to Investors

Current Event

June 26, 2019

Deutsche Bank, Issuer & Investor Bond Forum, London, UK

Overview

Latest Reports and Handout

Quarterly Statement 1st Quarter 2019 Annual Report 2018 Investor Handout

April 26, 2019

Annual Stockholders' Meeting

The Annual Stockholders’ Meeting took place on Friday, April 26, 2019, at the World Conference Center Bonn, Germany.

ANNUAL REPORT

Annual Report 2018

Publication of our Full Year and Fourth Quarter 2018 results on February 27, 2019.

Uses and Safety Record

Let's Talk About Glyphosate

Learn About The Litigation

Glyphosate Litigation Facts

December 05, 2018 // London